Correlation between plasma markers combined with muscular ultrasound and ICU-acquired-weakness in sepsis patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045709

Enrollment

Unknown

Registered

2021-04-23

Start date

2021-04-23

Completion date

Unknown

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU-acquired-weakness in sepsis patients

Interventions

case series:no

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with sepsis based on the definition of sepsis 3.0; 2. Aged >= 18 years.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from immunodeficiency diseases and using immunosuppressive or antitumor drugs; 2. Previous craniocerebral trauma, history of cerebrovascular disease (cerebral hemorrhage, cerebral infarction), craniocerebral tumor, central nervous system infection, spinal cord injury, Guillain-barre syndrome, porphyrin neuropathy, paraneoplastic neuropathy and other neuromuscular weakness diseases; 3. Coma state, limb joint surgery, fracture, lower limb thrombosis and other patients must be immobilized; 4. Patients admitted to ICU for 72 hours or less.

Design outcomes

Primary

Measure	Time frame
adriceps size and quality;	—

Countries

China

Contacts

Public ContactQin Bingyu

Henan Provincial People's Hospital

qinbyu@126.com+86 13633810677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026